Disclosures: Alexandra McCullough: Nothing to Disclose, Marina Serper: Transplant Genomics: Grant/Research Support, Grifols: Grant/Research Support, Eurofins: Grant/Research Support, David Kaplan: AstraZeneca Inc: Grant/Research Support, Roche Genentech: Independent Contractor, Exact Sciences: Grant/Research Support, Glycotest: Grant/Research Support, Sirtex: Advisor, Exelixis: Advisor, AstraZeneca: Advisor, Nadim Mahmud: Nothing to Disclose 2203 THE ASSOCIATION BETWEEN ALBUMIN ADMINISTRATION AND ACUTE KIDNEY INJURY OUTCOMES IN PATIENTS HOSPITALIZED WITH SPONTANEOUS BACTERIAL PERITONITIS Marina Serper 1 Alexandra McCullough 2 David Kaplan 3 Nadim Mahmud 2 , 1 University of Pennsylvania Health System, 2 Hospital of the University of Pennsylvania, 3 University of Pennsylvania Background: Patients who have cirrhosis decompensated by ascites are at risk for spontaneous bacterial peritonitis (SBP)
Incorporating bacteriophages into nanomaterials, such as functionalized NPs, enables particular antimicrobial activity without disrupting commensal microorganisms
2 oz Formula: Provides 30 days of support when administered at the standard dose (6 sprays, twice daily)
Stress can also lead to sudden weight gain or loss and can even influence other lifestyle factors like diet, alcohol consumption, and exercise, all of which can lead to changes with your hormones and your menstrual cycle
Green offers a host of treatment options for various forms of facial and bodily hyperpigmentation, helping patients of every skin tone and skin type achieve a brighter, clearer, more even skin tone that lasts
W., Schweizer, U., and Conrad, M
